EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study

Alyson W Wong iD, Karen C Tran, Mawuena Binka, Naveed Z Janjua, Hind Sbihi, James A Russell, Christopher Carlsten, Adeera Levin, Christopher J Ryerson

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286588 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Alyson W Wong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Quality of Life, COVID-19. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Lung Association & Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We sought to 1) identify long COVID phenotypes based on patient reported outcome measures (PROMs) and 2) determine whether the phenotypes were associated with quality of life (QoL) and/or lung function.

Methods

This was a longitudinal cohort study of hospitalized and non-hospitalized patients from March 2020 to January 2022 that was conducted across 4 Post-COVID Recovery Clinics in British Columbia, Canada. Latent class analysis was used to identify long COVID phenotypes using baseline PROMs (fatigue, dyspnea, cough, anxiety, depression, and post-traumatic stress disorder). We then explored the association between the phenotypes and QoL (using the EuroQoL 5 dimensions visual analogue scale [EQ5D VAS]) and lung function (using the diffusing capacity of the lung for carbon monoxide [DLCO]).

Results

There were 1,344 patients enrolled in the study (mean age 51 ±15 years; 780 [58%] were females; 769 (57%) were of a non-White race). Three distinct long COVID phenotypes were identified: Class 1) fatigue and dyspnea, Class 2) anxiety and depression, and Class 3) fatigue, dyspnea, anxiety, and depression. Class 3 had a significantly lower EQ5D VAS at 3 (50±19) and 6 months (54 ± 22) compared to Classes 1 and 2 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeCOVID-19FemaleHumansMaleLongitudinal StudiesPost-Acute COVID-19 SyndromeLatent Class AnalysisDyspneaPatient Reported Outcome MeasuresFatigueBritish Columbia

Autor:innen und Institutionen

  • Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.
  • Division of General Internal Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Data and Analytic Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Alyson W Wong

Förderung

  • CIHR
  • Canadian Lung Association & Canadian Institutes of Health Research

Zitieren

APA

Wong, A. W., Tran, K. C., Binka, M., Janjua, N. Z., Sbihi, H., Russell, J. A., Carlsten, C., Levin, A., & Ryerson, C. J. (2023). Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study. PLOS ONE. https://doi.org/10.1371/journal.pone.0286588

Vancouver

Wong AW, Tran KC, Binka M, Janjua NZ, Sbihi H, Russell JA, et al. Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study. PLOS ONE. 2023. doi:10.1371/journal.pone.0286588

BibTeX
@article{Wong2023,
  author = {Wong, Alyson W and Tran, Karen C and Binka, Mawuena and Janjua, Naveed Z and Sbihi, Hind and Russell, James A and Carlsten, Christopher and Levin, Adeera and Ryerson, Christopher J},
  title = {Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286588}
}
Kostenlos starten →